Black Rock Inc. Editas Medicine, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 7,782,517 shares of EDIT stock, worth $9.73 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,782,517
Previous 7,832,781
0.64%
Holding current value
$9.73 Million
Previous $58.1 Million
37.47%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding EDIT
# of Institutions
248Shares Held
57MCall Options Held
410KPut Options Held
394K-
Vanguard Group Inc Valley Forge, PA6.68MShares$8.35 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.9MShares$6.13 Million0.62% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.35MShares$4.19 Million0.01% of portfolio
-
State Street Corp Boston, MA2.46MShares$3.08 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.27MShares$2.83 Million0.0% of portfolio
About Editas Medicine, Inc.
- Ticker EDIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,737,200
- Market Cap $85.9M
- Description
- Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...